Recall
Class II — QIAGEN
| Recalling firm | QIAGEN, GmbH |
|---|---|
| Registered facility | View this company's 2 registered facilities → (openFDA recall records do not name a specific facility) |
| Classification | Class II |
| Status | Terminated |
| Reason | Underfilled reagent well that could lead to incorrect results |
| Product | EZ1 DSP Virus Kit (48), IVD, REF 62724 intended for in vitro diagnostic use. |
| Quantity | 287 pcs |
| Distribution | Domestic - MD Internationally - AE, AU , CZ, DE, DZ, ES, FR, GB, HK , IE, IT, NO, RO & SA |
| Initiated | 2018-05-28 |
| Classified | 2018-08-02 |
| Terminated | 2019-04-05 |
| Recall number | Z-2596-2018 |
| Initiation | Voluntary: Firm initiated |
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)
Cite this record
RegWarden. “Class II recall — QIAGEN (Z-2596-2018).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/80430/
Not open yet
Alerts for QIAGEN, GmbH
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Planned
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.